Met Life Investment Management, LLC I Bio, Inc. Transaction History

Met Life Investment Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$0.55 - $1.04 $45,746 - $86,503	-83,176 Closed	0 $0
Q3 2021 May 17, 2024	BUY	$1.06 - $1.52 $76,806 - $110,137	72,459 Added 676.11%	83,176 $88,000
Q3 2021 Jun 21, 2023	BUY	$1.06 - $1.52 $88,166 - $126,427	83,176 New	83,176 $88,000
Q3 2021 Mar 22, 2023	BUY	$1.06 - $1.52 $76,806 - $110,137	72,459 Added 676.11%	83,176 $88,000
Q3 2021 Nov 15, 2021	BUY	$1.06 - $1.52 $88,166 - $126,427	83,176 New	83,176 $88,000
Q2 2021 Aug 16, 2021	SELL	$1.22 - $1.65 $13,074 - $17,683	-10,717 Closed	0 $0
Q1 2021 May 17, 2024	BUY	$1.18 - $2.62 $12,646 - $28,078	10,717 New	10,717 $16,000
Q1 2021 Jun 26, 2023	BUY	$1.18 - $2.62 $12,646 - $28,078	10,717 New	10,717 $16.5 Million
Q1 2021 Mar 22, 2023	BUY	$1.18 - $2.62 $12,646 - $28,078	10,717 New	10,717 $16,000
Q1 2021 May 14, 2021	BUY	$1.18 - $2.62 $12,646 - $28,078	10,717 New	10,717 $17,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $24M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Met Life Investment Management, LLC with notifications on news.